Avindra Nath reports the intensive NIH intramural ME/CFS study achieved its goal: finding consistent biological abnormalities that point to possible treatment options. You might be forgiven for thinking that #MEAction is “just” an advocacy organization....
(After over 30 years in science policy, Michael Sieverts never dreamed he’d be the one in a study, but there he was, roughly 8 months after coming down with long COVID, in Avindra Nath’s neurological long COVID study. Thanks to Michael for sharing his...
We’re moving into a prime advocacy period. This is the second of a series of blogs on advocacy that are going to appear over the next month. The first focused on the big advocacy event of the year – the Solve ME/CFS Initiative’s Lobby Day. If...
“The story is always the same. When a pandemic happens, people always focus on the primary organ, but they forget about the brain.” Avindra Nath, MD Most researchers, when they focus on post-infectious illnesses, go straight to the body to figure...
The fact that ME/CFS is a mystery doesn’t daunt the leader of the NIH’s big intramural study on ME/CFS at all. Just a couple of years ago Avindra Nath and his compatriots cracked a mysterious neurodegenerative disease in East Africa that researchers had...
